1. Previous radiological (US and/or CT) proven episode of diverticulitis; |
---|
2. US and/or CT suspicion of colonic cancer |
3. Inflammatory bowel disease (ulcerative colitis, Crohn's disease); |
4. Hinchey stages 2, 3 and 4 or "severe" diverticulitis according to the Ambrosetti criteria, which require surgical or percutaneous treatment; |
5. Other disease with expected survival of less than 6 months; |
6. Contraindication for the use of the study medication (e.g. patients with advanced renal failure or allergy to antibiotics used in this study); |
7. Pregnancy; |
8. ASA (American Society of Anesthesiologists) classification > III; |
9. Immunocompromised patient; (i.e., haematological malignancies, AIDS patients with low CD4+ counts, transplantation, chemotherapy, splenectomy, long-term corticosteroid use and genetic disorders such as severe combined immunodeficiency. |
10. Clinical suspicion of bacteraemia (i.e. sepsis); |
11. The ability of reading/understanding and filling in the questionnaires. |
12. Antibiotic use in the 4 weeks prior to inclusion |